Breast cancer is a disease that overwhelmingly affects women, but men can get it too. Peter Bagnall is one of them.
Peter, 56, who is from Birmingham, got in touch with BBC Radio 5 Live during a discussion about women choosing to “go flat” instead of having reconstruction after breast cancer.
Here, in this own words, is Peter’s story of how he struggled following his breast cancer diagnosis, and how he and his partner Lorraine, who also had the condition, coped.
Evgen Pharma PLC (LON:EVG) is a clinical stage drug development company focused on cancer and neurological disease. Their pipeline is based on their proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane.